CervoMed Inc. (CRVO) Stock Analysis

CervoMed Inc. (CRVO) is a publicly traded company in the HEALTHCARE sector. It trades at $3.00, carries a market capitalization of $27.78M. This page summarizes the public market data, fundamentals, and frequently asked questions for CRVO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.00
• Market Cap: $27.78M
• EPS: $-3.28
• 52-Week High: $11.25
• 52-Week Low: $2.81

Market Sentiment

CervoMed Inc. currently has a Neutral sentiment score of -0.04.

About CervoMed Inc.

CervoMed Inc. is a clinical-stage biotechnology company based in Boston, Massachusetts, dedicated to developing innovative therapeutic solutions for neurodegenerative diseases, including Alzheimer's and Parkinson's. By harnessing advanced research methodologies and a promising drug pipeline, CervoMed seeks to fulfill significant unmet medical needs in these challenging fields. With a strategic focus on drug development, the company is well-positioned to become a key player in the transformati...

GNG Research Analysis

GNG Research scores CervoMed Inc. (CRVO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRVO.

Frequently Asked Questions

Does CRVO pay dividends?

CervoMed Inc. (CRVO) does not currently pay a regular dividend.

What is CRVO's market cap?

CervoMed Inc. (CRVO) has a market capitalization of $27.78M with a current stock price of $3.00.